117 related articles for article (PubMed ID: 31109254)
1. Association of 32-bp deletion polymorphism and promoter methylation of
Badawy AA; El-Rabat A; Elshazly TA; Ali SA; Alruwaili AM; Gad DF; Dawoud MG; Elmasry EE; Zaki ME
Br J Biomed Sci; 2019 Oct; 76(4):195-197. PubMed ID: 31109254
[No Abstract] [Full Text] [Related]
2.
Badawy AA; Othman G; Elabbasy LM; Abd Elsalam M; Shrief R; Fahmy EM; Kamel NM; Osman A; Zaki ME
Br J Biomed Sci; 2019 Oct; 76(4):201-204. PubMed ID: 31314698
[No Abstract] [Full Text] [Related]
3. Impact of hepatitis virus and aging on DNA methylation in human hepatocarcinogenesis.
Nishida N
Histol Histopathol; 2010 May; 25(5):647-54. PubMed ID: 20238302
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
[TBL] [Abstract][Full Text] [Related]
5. Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients.
Abo El-Khair SM; Elalfy H; Diasty M; Ebrahim EE; Elsamanoudy AZ
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22886. PubMed ID: 34392581
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Wirtz TH; Fischer P; Backhaus C; Bergmann I; Brandt EF; Heinrichs D; Koenen MT; Schneider KM; Eggermann T; Kurth I; Stoppe C; Bernhagen J; Bruns T; Fischer J; Berg T; Trautwein C; Berres ML
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370326
[TBL] [Abstract][Full Text] [Related]
7. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
8. An intronic single nucleotide polymorphism in the MUTYH gene is associated with increased risk for HCV-induced hepatocellular carcinoma.
Sakurada A; Miyanishi K; Tanaka S; Sato M; Sakamoto H; Kawano Y; Takada K; Nakabeppu Y; Kobune M; Kato J
Free Radic Biol Med; 2018 Dec; 129():88-96. PubMed ID: 30218772
[TBL] [Abstract][Full Text] [Related]
9. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
10. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population.
Maryam M; Idrees M
J Med Virol; 2018 Sep; 90(9):1516-1523. PubMed ID: 29742286
[TBL] [Abstract][Full Text] [Related]
11. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of promoter region of SPINT2/HAI-2 gene: an epigenetic mechanism in hepatitis C virus-induced hepatocarcinogenesis.
Ramadan RA; Zaki MA; Awad AM; El-Ghalid LA
Genet Test Mol Biomarkers; 2015 Jul; 19(7):399-404. PubMed ID: 26030814
[TBL] [Abstract][Full Text] [Related]
13. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
14. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression.
Fakhir FZ; Lkhider M; Badre W; Alaoui R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2016 Apr; 39():141-146. PubMed ID: 26827631
[TBL] [Abstract][Full Text] [Related]
15. The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.
Okamoto K; Ishida C; Ikebuchi Y; Mandai M; Mimura K; Murawaki Y; Yuasa I
Intern Med; 2010; 49(10):887-95. PubMed ID: 20467172
[TBL] [Abstract][Full Text] [Related]
16. Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma.
Deng YB; Nagae G; Midorikawa Y; Yagi K; Tsutsumi S; Yamamoto S; Hasegawa K; Kokudo N; Aburatani H; Kaneda A
Cancer Sci; 2010 Jun; 101(6):1501-10. PubMed ID: 20345479
[TBL] [Abstract][Full Text] [Related]
17. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6-174 Promoter Polymorphism and Susceptibility to Hepatitis B Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Iran.
Attar M; Azar SS; Shahbazi M
Asian Pac J Cancer Prev; 2016; 17(5):2395-9. PubMed ID: 27268603
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogentic profiles of hepatitis C infection in patients at Sharkia Governorate, Egypt.
el-Sobky E; Mangoud AM; Mahrous S; Eissa MH; Sabee EI; Ibrahem IA; Ismail A; Morsy TA; Nor Edin E; el-Naggar I; Mostafa Y; Abuel-Magd Y; Afefy AF; el-Shorbagy E; el-Sadawy M; Ragab H; el-Far A; Hassan MI; Lakouz K; Abdel-Aziz K; Saber M; el-Hady G
J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):401-15. PubMed ID: 15124749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
